Patent ID: 9181236
Filing Date: 2015-11-10
Classification: A61K,A61P,C07D

Abstract:
1. A compound, or a pharmaceutically acceptable salt thereof, said compound having the structural Formula (I): or a tautomer thereof, or a pharmaceutically acceptable salt of said tautomer, said tautomer thereof having the structural Formula (I′): wherein: W is selected from the group consisting of S, S(O), and S(O) ring C is selected from the group consisting of: ring A is selected from the group consisting of aryl, monocyclic heteroaryl, monocyclic cycloalkyl, monocyclic cycloalkenyl, monocyclic heterocycloalkyl, monocyclic heterocycloalkenyl, and a multicyclic group; ring B (when present) is independently selected from the group consisting of aryl, monocyclic heteroaryl, monocyclic cycloalkyl, monocyclic cycloalkenyl, monocyclic heterocycloalkyl, monocyclic heterocycloalkenyl, and a multicyclic group; -L m, n, and p are each independently selected integers, wherein: m is 0 or more; n is 0 or 1; and p is 0 or more, wherein the maximum value of m is the maximum number of available substitutable hydrogen atoms on ring A, and wherein the maximum value of p is the maximum number of available substitutable hydrogen atoms on ring B; each R each R each R each R R each R each R each R each R R each R each R each R each R